Serum PCSK9 levels were measured in 100 patients with autoimmune liver diseases — 57 with primary sclerosing cholangitis (PSC), 33 with primary biliary cholangitis (PBC), and 10 with autoimmune hepatitis (AIH)—and 88 healthy controls. This evidence concerns the gene PCSK9 and biliary liver cirrhosis.